Tag: Glenmark Pharmaceuticals
- 22 Sep
Glenmark Pharma stock falls on stake sale in Glenmark Life Sciences
Glenmark Pharma stock fell after the company announced it would sell a 75% stake in its subsidiary Glenmark Life Sciences to Nirma. Analysts expect the stake sale to benefit Glenmark Pharma, as it will transition from a net debt position to a cash surplus position. This is expected to have a positive impact on the company's return ratios over the next two to three years.
News Categories
Tag Cloud
Asian markets
Bank Nifty
Brokerage Recos - Currencies
Business
Buy
Buzzing Stocks
Commodities
Companies
Current Affairs
Economy
EMs
F&O Manual
ICICI Direct
India
IPO
IPO - Issues Open
IPO - News
IPO - Upcoming Issues
Local Markets
Market Cues
Market Edge
MARKET OUTLOOK
markets
Motilal Oswal
mutual funds
Nifty
Nifty Bank
Politics
Real Estate
Recommendations
RR Kabel
rupee
Sell
Sensex
Sharekhan
Signature Global
Slideshow
stocks in the news
Stocks Views
Taking Stock
Technicals
Technical View
USDINR
World News
Zaggle Prepaid Ocean Services